Targeting the LINC00265/miR-485-5p axis for diagnosis and therapeutic intervention in breast cancer
Significantly upregulated LINC00265 is a biomarker for the diagnosis of breast cancer, and LINC00265 binds to miR-485-5p to mediate tumor progression.
Authors
- Suya Han (ORCID: https://orcid.org/0009-0003-9075-8818)
- Ru Chang
- Jianzhen Pan
- Bingjie Zhang (ORCID: https://orcid.org/0000-0002-0535-0371)
- Qiang Jiang (ORCID: https://orcid.org/0009-0000-5316-6723)
Institutions
- Hebei Medical University (CN)
- Central South University (CN)
- Harbin Medical University (CN)
- Xingtai People's Hospital (CN)
- Hunan Cancer Hospital (CN)
- Henan Provincial People's Hospital (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1007/s12672-025-03811-6
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00